Scientists have obtained stem cells from pigs, sheep, and cattle without the need for serum, feeder cells, or antibiotics to pave the way for “manufacturing cell-cultured meat and breeding enhanced livestock”.
The researchers for the study were mainly from the University of Nottingham’s School of Biosciences in the UK, in collaboration with the Universities of Cambridge, Exeter, Tokyo, and Meijit.
According to the lead researcher, Ramiro Alberio, the ability to derive and maintain livestock stem cells under chemically defined conditions allows the development of novel food products, such as cultured meat.
He added that the newly-developed cell lines are a step-change from previous models for their unique ability to permanently grow to make muscle and fat.”
The stem cell lines can develop into multiple cell types, which can then be genetically manipulated through the Crispr/Cas9 gene-editing tool.
The results could broaden research into gene editing animals to improve productivity, adaptation to climate change, diet modifications, and the environmental impact of livestock production.
Alberio added the results allow gene editing to happen naturally over a long time selectively and rapidly to customize specific traits. This can accelerate the pace of genetic selection of livestock and cultured meat to improve productivity and the creation of healthier foods.
The research offers potential solutions that the food industry could use at scale amid a growing population to feed in a changing climate.
According to the study, the new chemically defined approach provides greater consistency and safety than the use of serum, making it an ideal solution for manufacturing new lab-grown food products.”.
It added that the use of serum has technical disadvantages, including its undefined nature, batch-to-batch variability in composition, and the risk of contamination.
The research, titled “Pluripotent stem cells related to embryonic disc exhibit common self-renewal requirements in diverse livestock species,” was published in the Development journal.
It was funded by BBSRC, EU (ERC), MRC and Wellcome Trust.


Japan CPI Rises in June, but Core Inflation Stays Below BOJ’s 2% Target
Global Leaders Push Back as Trump Imposes New Forced Labor Tariffs
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Australia Jobs Surge in June Strengthens Case for More RBA Rate Hikes
Uber Stock Falls as Waymo Plans to End Robotaxi Partnership by 2028
US Dollar Posts Best Weekly Gain in Over a Month as Middle East Tensions Boost Safe-Haven Demand
Samsung Eyes Up to $1.14 Billion Investment in AI Startup Mistral
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
China vs. NASA: The New Moon Race and What's at Stake by 2030
Brent Oil Holds Above $100 as Red Sea Attacks, Iran Conflict Threaten Global Supply
Oil Prices Pull Back After Two-Week Rally as Middle East Supply Risks Persist
Intel, AMD Seek Long-Term China Server CPU Deals as AI Demand Drives Supply Crunch
Intel Stock Slips After Earnings Rally Despite Strong AI-Driven Revenue Growth
Amkor Stock Surges 17% After $1.5 Billion Nvidia AI Packaging Partnership
Asian Stocks Rally on AI Spending Optimism as Middle East Tensions Push Oil to Six-Week High
Tabletop particle accelerator could transform medicine and materials science 



